Immediate Impact

8 standout
Sub-graph 1 of 4

Citing Papers

The evolution of commercial drug delivery technologies
2021 Standout
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation
2019 Standout
1 intermediate paper

Works of W.A. Long being referenced

2010 Q2WEEK CONTROLLED-RELEASE-INTERFERON-ALPHA2B + RIBAVRIN REDUCES FLU-LIKE SYMPTOMS >50% AND PROVIDES EQUIVALENT EFFICACY IN COMPARISON TO WEEKLY PEGYLATED-INTERFERON-ALPHA2B + RIBAVIRIN IN TREATMENT-NAIVE-GENOTYPE-1-CHRONIC-HEPATITIS-C: RESULTS FROM EMPOWER, A RANDOMIZED-OPEN-LABEL-12-WEEK-COMPARISON IN 133 PATIENTS
2010

Author Peers

Author Last Decade Papers Cites
W.A. Long 19 18 4 6 21
Keyur Patel 19 17 2 6 27
Bebi Yassin-Rajkumar 13 15 6 4 17
Bastian Neesgaard 12 8 1 5 4 20
Maria Cássia Mendes Corrêa 8 13 3 6 6 25
Min-Feng Liang 16 20 8 5 23
S. Maier 17 14 2 2 5 22
Ventzislava Petrov–Sanchez 10 12 1 3 6 32
Mario Meier 10 17 3 4 19
Simona Erşcoiu 7 11 7 8 20
Antônio Matera 21 20 1 1 6 32

All Works

Loading papers...

Rankless by CCL
2026